MEDICINAL MASSAGE OIL

MEDICINAL MASSAGE OIL was reported 230 times

MEDICINAL MASSAGE OIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SLEEP DISORDER THERAPY 88 0.4444
1 ANTACID THERAPY 48 0.3692
2 APPENDICOLITH 131 0.3385
3 ANALGESIC THERAPY 89 0.2773
4 DRUG THERAPY 86 0.2537
5 CONGENITAL HIATUS HERNIA 49 0.2149
6 MALIGNANT MELANOMA STAGE 0 40 0.1914
7 ANTICOAGULANT THERAPY 48 0.1690
8 BACTEROIDES INFECTION 30 0.1149
9 HYPERPHOSPHATAEMIA 107 0.0497
10 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 43 0.0464
11 BLOOD PHOSPHORUS INCREASED 121 0.0443
12 APPLICATION SITE ATROPHY 1 0.0303
13 TOTAL LUNG CAPACITY DECREASED 39 0.0244
14 VENTRICLE RUPTURE 3 0.0221
15 IRON DEFICIENCY 78 0.0173
16 BLOOD URIC ACID INCREASED 100 0.0173
17 HYPOPHOSPHATAEMIA 117 0.0158
18 MYASTHENIA GRAVIS 125 0.0155
19 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 77 0.0152
20 APPENDICITIS 131 0.0140
21 LUNG OPACITY 36 0.0136
22 PLEURITIC PAIN 37 0.0134
23 AORTIC STENOSIS 43 0.0123
24 RESPIRATORY SYMPTOM 34 0.0119
25 VENTRICULAR FIBRILLATION 132 0.0119
26 CARDIOGENIC SHOCK 127 0.0088
27 LIVER FUNCTION TEST 1 0.0085
28 BENIGN PROSTATIC HYPERPLASIA 42 0.0081
29 TROPONIN INCREASED 61 0.0080
30 BREATH SOUNDS ABNORMAL 35 0.0071
31 BLOOD CALCIUM INCREASED 59 0.0067
32 BACTERIAL INFECTION 115 0.0062
33 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 101 0.0059
34 HYPERLIPIDAEMIA 63 0.0053
35 MULTIPLE ORGAN DYSFUNCTION SYNDROME 149 0.0053
36 NEURALGIA 120 0.0049
37 ASCITES 131 0.0045
38 ULCER 68 0.0043
39 BLOOD TEST ABNORMAL 58 0.0041
40 ASPARTATE AMINOTRANSFERASE 1 0.0041
41 DEVICE ALLERGY 1 0.0040
42 ASPIRATION 43 0.0039
43 GOUT 69 0.0038
44 HYPERCHOLESTEROLAEMIA 36 0.0037
45 END STAGE RENAL DISEASE 68 0.0037
46 FULL BLOOD COUNT ABNORMAL 36 0.0034
47 MICTURITION URGENCY 38 0.0033
48 CAUSTIC INJURY 1 0.0032
49 HYPONATRAEMIA 152 0.0027
50 VASCULAR GRAFT OCCLUSION 1 0.0026
51 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 2 0.0025
52 RALES 14 0.0024
53 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 120 0.0023
54 BLOOD CHOLESTEROL INCREASED 100 0.0021
55 BRONCHIECTASIS 14 0.0021
56 INCORRECT DOSE ADMINISTERED BY PRODUCT 3 0.0019
57 JOINT INJURY 40 0.0019
58 MEASLES 1 0.0019
59 TRANSAMINASES INCREASED 39 0.0018
60 IRON DEFICIENCY ANAEMIA 15 0.0016
61 DIABETES MELLITUS 123 0.0016
62 DRY MOUTH 126 0.0016
63 SLEEP DISORDER 107 0.0015
64 THROMBOSIS 120 0.0015
65 SPUTUM DISCOLOURED 14 0.0015
66 APPLICATION SITE ULCER 1 0.0014
67 BENIGN NEOPLASM OF THYROID GLAND 1 0.0014
68 LOWER RESPIRATORY TRACT INFECTION 62 0.0014
69 CORONARY ARTERY DISEASE 41 0.0014
70 SEPSIS 150 0.0013
71 CARDIOVASCULAR DISORDER 34 0.0013
72 INTENTIONAL PRODUCT MISUSE 116 0.0013
73 GENERAL PHYSICAL HEALTH DETERIORATION 151 0.0013
74 ABDOMINAL DISTENSION 136 0.0013
75 SWELLING 121 0.0013
76 DRUG INTOLERANCE 123 0.0013
77 OBSTRUCTIVE AIRWAYS DISORDER 14 0.0013
78 GOUTY ARTHRITIS 1 0.0013
79 PULMONARY EMBOLISM 118 0.0012
80 LIVER FUNCTION TEST INCREASED 26 0.0012
81 MEAN PLATELET VOLUME DECREASED 1 0.0012
82 TRANSIENT ISCHAEMIC ATTACK 38 0.0011
83 MYELOPATHY 2 0.0011
84 PULMONARY MASS 14 0.0009
85 BLOOD CREATININE INCREASED 59 0.0009
86 UPPER RESPIRATORY TRACT INFECTION 41 0.0009
87 MALIGNANT MELANOMA IN SITU 1 0.0008
88 PRODUCT USED FOR UNKNOWN INDICATION 1 0.0008
89 HAEMOPTYSIS 21 0.0008
90 LIVER DISORDER 33 0.0007
91 SOMNOLENCE 148 0.0007
92 DRUG SPECIFIC ANTIBODY 1 0.0007
93 PULMONARY FIBROSIS 14 0.0007
94 MUSCULOSKELETAL STIFFNESS 62 0.0007
95 PLEURAL EFFUSION 41 0.0007
96 LUNG DISORDER 32 0.0007
97 ANAEMIA 116 0.0006
98 CONSTIPATION 129 0.0006
99 ABDOMINAL PAIN 131 0.0006
100 INJECTION SITE DISCHARGE 3 0.0006
101 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
102 CONDITION AGGRAVATED 154 0.0005
103 CARDIAC DISCOMFORT 1 0.0005
104 PLATELET COUNT ABNORMAL 3 0.0005
105 OEDEMA PERIPHERAL 60 0.0005
106 ASPARTATE AMINOTRANSFERASE INCREASED 26 0.0005
107 BLOOD CREATINE INCREASED 2 0.0005
108 SUSPECTED OFF LABEL USE 2 0.0004
109 GASTROINTESTINAL DISORDER 38 0.0004
110 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
111 URINARY TRACT INFECTION BACTERIAL 1 0.0004
112 ASTHMA 44 0.0004
113 HYPOXIA 13 0.0004
114 HYPERTENSION 67 0.0003
115 PRODUCT USE IN UNAPPROVED INDICATION 75 0.0003
116 VOMITING 133 0.0003
117 AUTOIMMUNE THYROIDITIS 1 0.0003
118 COMMUNICATION DISORDER 1 0.0003
119 PULMONARY TUBERCULOSIS 1 0.0002
120 TREMOR 38 0.0002
121 VULVOVAGINAL DISCOMFORT 1 0.0002
122 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 40 0.0002
123 VASCULAR DEVICE INFECTION 1 0.0002
124 VAGINAL INFECTION 1 0.0002
125 ENDOMETRIOSIS 1 0.0002
126 VULVOVAGINAL PAIN 1 0.0002
127 APPLICATION SITE BURN 1 0.0002
128 HYPOAESTHESIA ORAL 3 0.0002
129 ERYSIPELAS 1 0.0002
130 GASTROOESOPHAGEAL REFLUX DISEASE 15 0.0002
131 HYDROCEPHALUS 1 0.0002
132 PRODUCT LEAKAGE 1 0.0002
133 NAUSEA 133 0.0002
134 OSTEOMYELITIS 3 0.0002
135 INGUINAL HERNIA 1 0.0002
136 DYSPNOEA 92 0.0002
137 OFF LABEL USE 142 0.0002
138 PROCTALGIA 1 0.0002
139 APPLICATION SITE VESICLES 1 0.0002
140 WHEEZING 9 0.0002
141 PRODUCT ADMINISTRATION ERROR 3 0.0001
142 APPLICATION SITE RASH 2 0.0001
143 PRODUCT DOSE OMISSION ISSUE 42 0.0001
144 PNEUMONIA 41 0.0001
145 LOCALISED INFECTION 3 0.0001
146 DECUBITUS ULCER 1 0.0001
147 PYREXIA 41 0.0001
148 ANURIA 1 0.0001
149 ASTHENIA 41 0.0001
150 THROMBOTIC MICROANGIOPATHY 1 0.0001
151 VAGINAL DISCHARGE 1 0.0001
152 SUDDEN DEATH 1 0.0001
153 WOUND INFECTION 1 0.0001
154 BLOOD CALCIUM DECREASED 1 0.0001
155 GASTRIC HAEMORRHAGE 1 0.0001
156 BACTERAEMIA 1 0.0001
157 CYTOPENIA 1 0.0001
158 GENERALISED OEDEMA 1 0.0001
159 DYSPNOEA EXERTIONAL 3 0.0001
160 DERMATITIS ALLERGIC 1 0.0001
161 BEDRIDDEN 1 0.0001
162 OSTEOARTHRITIS 3 0.0001
163 SEASONAL ALLERGY 1 0.0001
164 DEATH 59 0.0001
165 RENAL DISORDER 3 0.0001
166 HEADACHE 40 0.0001
167 OCULAR HYPERAEMIA 3 0.0001
168 ABDOMINAL PAIN UPPER 13 0.0001
169 PAIN 37 0.0001
170 DRUG INEFFECTIVE 77 0.0001
171 SYRINGE ISSUE 1 0.0001
172 PELVIC PAIN 1 0.0001
173 EAR PAIN 1 0.0001
174 PSORIATIC ARTHROPATHY 2 0.0000
175 COUGH 13 0.0000
176 FATIGUE 36 0.0000
177 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
178 APPLICATION SITE PAIN 1 0.0000
179 APPLICATION SITE PRURITUS 1 0.0000
180 SHOCK 1 0.0000
181 CELLULITIS 2 0.0000
182 HEPATITIS 1 0.0000
183 SEDATION 1 0.0000
184 APPLICATION SITE ERYTHEMA 1 0.0000
185 CARDIAC ARREST 3 0.0000
186 INJECTION SITE RASH 1 0.0000
187 PSORIASIS 4 0.0000
188 FEBRILE NEUTROPENIA 2 0.0000
189 GAIT INABILITY 1 0.0000
190 NIGHTMARE 1 0.0000
191 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
192 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
193 INFLUENZA 3 0.0000
194 DEVICE BREAKAGE 1 0.0000
195 VISUAL IMPAIRMENT 3 0.0000
196 NEPHROLITHIASIS 1 0.0000
197 TINNITUS 1 0.0000
198 HYPOKALAEMIA 1 0.0000
199 PRODUCTIVE COUGH 1 0.0000
200 PLATELET COUNT DECREASED 2 0.0000
201 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
202 MEDICATION ERROR 1 0.0000
203 VISION BLURRED 2 0.0000
204 CHRONIC KIDNEY DISEASE 1 0.0000
205 ARTHRITIS 1 0.0000
206 CARDIAC FAILURE 1 0.0000
207 DRUG ABUSE 1 0.0000
208 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
209 DEVICE ISSUE 1 0.0000
210 MIGRAINE 1 0.0000
211 GAIT DISTURBANCE 2 0.0000
212 INJECTION SITE PAIN 3 0.0000
213 LOSS OF CONSCIOUSNESS 1 0.0000
214 HYPERHIDROSIS 1 0.0000
215 RENAL FAILURE 1 0.0000
216 NEUTROPENIA 1 0.0000
217 DRUG INTERACTION 1 0.0000
218 URINARY TRACT INFECTION 1 0.0000
219 DIARRHOEA 3 0.0000
220 RASH 2 0.0000
221 DEPRESSION 1 0.0000
222 INCORRECT DOSE ADMINISTERED 1 0.0000
223 INSOMNIA 1 0.0000
224 FALL 1 0.0000
225 DIZZINESS 1 0.0000